MEDICINOVA, INC. Investing Cash Flow
MEDICINOVA, INC. (MNOV) reported Investing Cash Flow of -$10.82 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- MEDICINOVA, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- MEDICINOVA, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$10.82K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MEDICINOVA, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.90K, a 1602.07% decline year-over-year.
- MEDICINOVA, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$2.90K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$697.00, a 100.00% decline from fiscal 2023.
- MEDICINOVA, INC. net cash provided by (used in) investing activities for fiscal 2023 was $39.91M.
- MEDICINOVA, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$40.01M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 129 month | Net Cash Provided by (Used in) Investing Activities 132 month | Net Cash Provided by (Used in) Investing Activities 135 month | Net Cash Provided by (Used in) Investing Activities 138 month | Net Cash Provided by (Used in) Investing Activities 141 month | Net Cash Provided by (Used in) Investing Activities 144 month | Net Cash Provided by (Used in) Investing Activities 147 month | Net Cash Provided by (Used in) Investing Activities 150 month | Net Cash Provided by (Used in) Investing Activities 153 month | Net Cash Provided by (Used in) Investing Activities 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$10.82K 10-Q · filed 2026-08-13 | -$10.82K derived: sum of 3 quarters · filed 2026-08-13 | -$13.72K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2026-03-31 | -$10.82K 10-Q · filed 2026-05-14 | -$10.82K derived: sum of 2 quarters · filed 2026-05-14 | -$13.72K derived: sum of 3 quarters · filed 2026-05-14 | -$13.72K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$2.90K derived: sum of 2 quarters · filed 2026-03-10 | -$2.90K derived: sum of 3 quarters · filed 2026-08-13 | -$2.90K 10-K · filed 2026-03-10 | ||||||||||
| 2025-09-30 | -$2.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.90K derived: sum of 2 quarters · filed 2026-08-13 | -$2.90K 10-Q · filed 2025-11-12 | -$2.90K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $1.00 derived: sum of 3 quarters · filed 2026-08-13 | $194.00 derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $1.00 derived: sum of 2 quarters · filed 2026-05-14 | $194.00 derived: sum of 3 quarters · filed 2026-05-14 | |||||||||||
| 2024-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $194.00 derived: sum of 2 quarters · filed 2026-03-10 | -$697.00 10-K · filed 2026-03-10 | |||||||||||
| 2024-09-30 | $193.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$698.00 10-Q · filed 2025-11-12 | ||||||||||||
| 2024-06-30 | -$891.00 10-Q · filed 2025-08-14 | |||||||||||||
| 2023-12-31 | $22.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$2.72K derived: sum of 2 quarters · filed 2025-02-19 | -$21.30K derived: sum of 3 quarters · filed 2025-02-19 | $39.91M 10-K · filed 2025-02-19 | ||||||||||
| 2023-09-30 | -$2.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$21.32K derived: sum of 2 quarters · filed 2024-11-13 | $39.91M 10-Q · filed 2024-11-13 | $9.90M derived: sum of 4 quarters · filed 2024-11-13 | ||||||||||
| 2023-06-30 | -$18.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $39.91M 10-Q · filed 2024-08-08 | $9.91M derived: sum of 3 quarters · filed 2024-08-08 | |||||||||||
| 2023-03-31 | $39.93M 10-Q · filed 2024-05-09 | $9.92M derived: sum of 2 quarters · filed 2024-05-09 | ||||||||||||
| 2022-12-31 | -$30.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$40.01M 10-K · filed 2024-02-15 | ||||||||||||
| 2022-09-30 | -$10.00M 10-Q · filed 2023-11-09 | |||||||||||||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | -$2.94K derived: sum of 2 quarters · filed 2023-03-28 | -$28.73K 10-K/A · filed 2023-03-28 | |||||||||||
| 2021-09-30 | -$2.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$28.73K 10-Q · filed 2022-11-10 | ||||||||||||
| 2021-06-30 | -$25.79K 10-Q · filed 2022-08-11 | |||||||||||||
| 2020-12-31 | -$32.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$33.89K derived: sum of 2 quarters · filed 2022-02-16 | -$33.90K derived: sum of 3 quarters · filed 2022-02-16 | -$36.49K 10-K · filed 2022-02-16 | ||||||||||
| 2020-09-30 | -$1.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.20K derived: sum of 2 quarters · filed 2021-11-12 | -$3.79K 10-Q · filed 2021-11-12 | -$11.05K derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||
| 2020-06-30 | -$10.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$2.60K 10-Q · filed 2021-08-12 | -$9.86K derived: sum of 3 quarters · filed 2021-08-12 | -$9.86K derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||
| 2020-03-31 | -$2.59K 10-Q · filed 2021-05-13 | -$9.85K derived: sum of 2 quarters · filed 2021-05-13 | -$9.85K derived: sum of 3 quarters · filed 2021-05-13 | -$11.91K derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||
| 2019-12-31 | -$7.26K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$7.26K derived: sum of 2 quarters · filed 2021-02-19 | -$9.32K derived: sum of 3 quarters · filed 2021-02-19 | -$11.27K 10-K · filed 2021-02-19 | ||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | -$2.06K derived: sum of 2 quarters · filed 2020-10-26 | -$4.01K 10-Q · filed 2020-10-26 | -$4.01K derived: sum of 4 quarters · filed 2020-10-26 | ||||||||||
| 2019-06-30 | -$2.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | -$4.01K 10-Q · filed 2020-07-28 | -$4.01K derived: sum of 3 quarters · filed 2020-07-28 | -$4.01K derived: sum of 4 quarters · filed 2020-07-28 | ||||||||||
| 2019-03-31 | -$1.95K 10-Q · filed 2020-04-23 | -$1.95K derived: sum of 2 quarters · filed 2020-04-23 | -$1.95K derived: sum of 3 quarters · filed 2020-04-23 | $632.96K derived: sum of 4 quarters · filed 2020-04-23 | ||||||||||
| 2018-12-31 | $7.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $7.00 derived: sum of 2 quarters · filed 2020-02-13 | $634.91K derived: sum of 3 quarters · filed 2020-02-13 | $626.32K 10-K · filed 2020-02-13 | ||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | $634.90K derived: sum of 2 quarters · filed 2019-10-24 | $626.32K 10-Q · filed 2019-10-24 | |||||||||||
| 2018-06-30 | $634.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $626.32K 10-Q · filed 2019-07-25 | ||||||||||||
| 2018-03-31 | -$8.58K 10-Q · filed 2019-04-25 | |||||||||||||
| 2016-12-31 | -$84.48K 10-K · filed 2019-02-13 | |||||||||||||
| 2013-12-31 | -$12.24K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $2.77K derived: sum of 2 quarters · filed 2014-03-27 | -$41.55K derived: sum of 3 quarters · filed 2014-03-27 | -$36.75K 10-K · filed 2014-03-27 | ||||||||||
| 2013-09-30 | $15.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$29.31K derived: sum of 2 quarters · filed 2013-11-07 | -$24.51K 10-Q · filed 2013-11-07 | -$24.72K derived: sum of 4 quarters · filed 2014-03-27 | -$4.93M 10-Q · filed 2013-11-07 | |||||||||
| 2013-06-30 | -$44.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$39.52K 10-Q · filed 2013-08-08 | -$39.72K derived: sum of 3 quarters · filed 2014-03-27 | -$73.56K derived: sum of 4 quarters · filed 2014-03-27 | -$4.94M 10-Q · filed 2013-08-08 | |||||||||
| 2013-03-31 | $4.80K 10-Q · filed 2013-05-08 | $4.60K derived: sum of 2 quarters · filed 2014-03-27 | -$29.24K derived: sum of 3 quarters · filed 2014-03-27 | -$70.55K derived: sum of 4 quarters · filed 2014-03-27 | -$4.90M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | -$202.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$34.04K derived: sum of 2 quarters · filed 2014-03-27 | -$75.35K derived: sum of 3 quarters · filed 2014-03-27 | -$763.38K 10-K · filed 2014-03-27 | -$4.90M 10-K · filed 2013-03-28 | |||||||||
| 2012-09-30 | -$33.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$75.15K derived: sum of 2 quarters · filed 2013-11-07 | -$763.18K 10-Q · filed 2013-11-07 | -$769.26K derived: sum of 4 quarters · filed 2013-11-07 | -$4.90M 10-Q · filed 2012-11-08 | |||||||||
| 2012-06-30 | -$41.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$729.34K 10-Q · filed 2013-08-08 | -$735.42K derived: sum of 3 quarters · filed 2013-08-08 | -$735.42K derived: sum of 4 quarters · filed 2013-08-08 | -$4.87M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | -$688.02K 10-Q · filed 2013-05-08 | -$694.11K derived: sum of 2 quarters · filed 2013-05-08 | -$694.11K derived: sum of 3 quarters · filed 2013-05-08 | -$4.83M 10-Q · filed 2012-05-10 | ||||||||||
| 2011-12-31 | -$6.08K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$6.08K derived: sum of 2 quarters · filed 2013-03-28 | -$6.08K 10-K · filed 2013-03-28 | -$4.14M 10-K · filed 2012-03-29 | ||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | -$4.13M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | -$4.13M 10-Q · filed 2011-08-15 | ||||||||||||
| 2010-12-31 | $631.45K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $12.17M derived: sum of 2 quarters · filed 2012-03-29 | $27.64M 10-K · filed 2012-03-29 | |||||||||||
| 2010-09-30 | $11.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $27.00M 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $15.46M 10-Q · filed 2011-08-15 | |||||||||||||
| 2009-12-31 | -$1.14M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |